Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.
Also called NCT02847091
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 103 participants
- Sponsor
- Registry
-
NCT02847091
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02847091. Allocation not applicable; no masking; primary purpose treatment. Start 2016-07-29 (actual); primary completion 2017-11-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Ipragliflozin
- Intervention (Drug)
- Insulin
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct02847091- Content hash
d8b4d28432e318090bec8516431a9268619439c8d5286db0c7a3cdfe16c64f1d